This is a preliminary program for the session.
Chairs
Announced soon
The programme
This is a preliminary program based on submitted abstracts from experts in the field. The scientific committee of ESAO 2025 has then brought them together in the sessions below. The speakers listed below must confirm their participation by purchasing a ticket before the early bird deadline (April 25).
Time | Presentation |
|---|---|
Welcome and introduction | |
18 min | In Vitro Assessment Of Catecholamine Adsorption Profiles During Hemoadsorption TherapyAndreas Körtge, Department of Extracorporeal Therapy Systems, Fraunhofer Institute for Cell Therapy and Immunology IZI, Germany; Division of Nephrology, Center for Internal Medicine, Rostock University Medical Center, Germany |
18 min | Study Of Embolic Agent Injection Via A Microfluidic-Based Model Of A Vascular NetworkJulien Massoni, Université de Technologie de Compiègne, CNRS, Biomechanics and Bioingineering (UMR 7338), France; Research and Innovation Department, Guerbet, France |
18 min | Immune-Endothelial Co-Culture Model With Madcam-1 To Study Vedolizumab Response In Crohn's DiseaseGloria Krajnc, Centre for human molecular genetics and pharmacogenomics, Faculty of Medicine, University of Maribor, Slovenia; Department for Science and Research, University Medical Centre Maribor, Slovenia |
18 min | Towards 3D In Vitro Personalized Tumor Models: Characterization Of Bioprinted Glioblastoma TissueGiuseppe D’Avenio, National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, Rome, Italy |
18 min | An In Silico Model Relating The Mechanics Of Cardiomyocytes To Cardiovsacular Haemodynamics For The Investigation Of Heart Failure And Related TherapiesAkhilesh Kamtikar, Cardiovascular and Respiratory Physiology, Technical Medical Centre, University of Twente, Enschede, The Netherlands |
Closing words |